Skip to main navigation Skip to search Skip to main content

Genotype-Phenotype Correlation in NF1: Evidence for a More Severe Phenotype Associated with Missense Mutations Affecting NF1 Codons 844–848

  • Magdalena Koczkowska
  • , Yunjia Chen
  • , Tom Callens
  • , Alicia Gomes
  • , Angela Sharp
  • , Sherrell Johnson
  • , Meng Chang Hsiao
  • , Zhenbin Chen
  • , Meena Balasubramanian
  • , Christopher P. Barnett
  • , Troy A. Becker
  • , Shay Ben-Shachar
  • , Debora R. Bertola
  • , Jaishri O. Blakeley
  • , Emma M.M. Burkitt-Wright
  • , Alison Callaway
  • , Melissa Crenshaw
  • , Karin S. Cunha
  • , Mitch Cunningham
  • , Maria D. D'Agostino
  • Karin Dahan, Alessandro De Luca, Anne Destrée, Radhika Dhamija, Marica Eoli, D. Gareth R. Evans, Patricia Galvin-Parton, Jaya K. George-Abraham, Karen W. Gripp, Jose Guevara-Campos, Neil A. Hanchard, Concepcion Hernández-Chico, La Donna Immken, Sandra Janssens, Kristi J. Jones, Beth A. Keena, Aaina Kochhar, Jan Liebelt, Arelis Martir-Negron, Maurice J. Mahoney, Isabelle Maystadt, Carey McDougall, Meriel McEntagart, Nancy Mendelsohn, David T. Miller, Geert Mortier, Jenny Morton, John Pappas, Scott R. Plotkin, Dinel Pond, Kenneth Rosenbaum, Karol Rubin, Laura Russell, Lane S. Rutledge, Veronica Saletti, Rhonda Schonberg, Allison Schreiber, Meredith Seidel, Elizabeth Siqveland, David W. Stockton, Eva Trevisson, Nicole J. Ullrich, Meena Upadhyaya, Rick van Minkelen, Helene Verhelst, Margaret R. Wallace, Yoon Sim Yap, Elaine Zackai, Jonathan Zonana, Vickie Zurcher, Kathleen Claes, Yolanda Martin, Bruce R. Korf, Eric Legius, Ludwine M. Messiaen
  • University of Alabama at Birmingham
  • Sheffield Children's NHS Foundation Trust
  • Women's and Children's Hospital Adelaide
  • Johns Hopkins University
  • Tel Aviv Sourasky Medical Center
  • Universidade de São Paulo
  • University of Manchester
  • Salisbury NHS Foundation Trust
  • Universidade Federal Fluminense
  • Children's Hospital of Michigan
  • McGill University
  • Institute of Pathology and Genetics (IPG)
  • IRCCS Ospedale Casa Sollievo della Sofferenza - San Giovanni Rotondo (FG)
  • Mayo Clinic Scottsdale-Phoenix, Arizona
  • IRCCS Fondazione Istituto Neurologico Carlo Besta - Milano
  • Dell Children's Medical Center of Central Texas
  • Alfred I. duPont Hospital for Children
  • University of Oriente
  • Baylor College of Medicine
  • Hospital Ramon y Cajal
  • Ghent University
  • The Children's Hospital at Westmead
  • University of Pennsylvania
  • Valley Children's Healthcare
  • Miami Cancer Institute
  • Yale University
  • St George's University Hospitals NHS Foundation Trust
  • Children's Hospitals and Clinics of Minnesota
  • Boston Children's Hospital
  • University of Antwerp
  • Birmingham Women's and Children's NHS Foundation Trust
  • New York University
  • Massachusetts General Hospital
  • Children's National Medical Center
  • University of Minnesota Twin Cities
  • Cleveland Clinic Foundation
  • University of Padua
  • Cardiff University
  • General Electric
  • University of Florida
  • National Cancer Centre
  • Adelaide University
  • Oregon Health and Science University
  • KU Leuven

Research output: Contribution to journalArticlepeer-review

187 Scopus citations

Abstract

Neurofibromatosis type 1 (NF1), a common genetic disorder with a birth incidence of 1:2,000–3,000, is characterized by a highly variable clinical presentation. To date, only two clinically relevant intragenic genotype-phenotype correlations have been reported for NF1 missense mutations affecting p.Arg1809 and a single amino acid deletion p.Met922del. Both variants predispose to a distinct mild NF1 phenotype with neither externally visible cutaneous/plexiform neurofibromas nor other tumors. Here, we report 162 individuals (129 unrelated probands and 33 affected relatives) heterozygous for a constitutional missense mutation affecting one of five neighboring NF1 codons—Leu844, Cys845, Ala846, Leu847, and Gly848—located in the cysteine-serine-rich domain (CSRD). Collectively, these recurrent missense mutations affect ∼0.8% of unrelated NF1 mutation-positive probands in the University of Alabama at Birmingham (UAB) cohort. Major superficial plexiform neurofibromas and symptomatic spinal neurofibromas were more prevalent in these individuals compared with classic NF1-affected cohorts (both p < 0.0001). Nearly half of the individuals had symptomatic or asymptomatic optic pathway gliomas and/or skeletal abnormalities. Additionally, variants in this region seem to confer a high predisposition to develop malignancies compared with the general NF1-affected population (p = 0.0061). Our results demonstrate that these NF1 missense mutations, although located outside the GAP-related domain, may be an important risk factor for a severe presentation. A genotype-phenotype correlation at the NF1 region 844–848 exists and will be valuable in the management and genetic counseling of a significant number of individuals.

Original languageEnglish
Pages (from-to)69-87
Number of pages19
JournalAmerican Journal of Human Genetics
Volume102
Issue number1
DOIs
StatePublished - Jan 4 2018

Keywords

  • CSRD
  • MPNST
  • NF1
  • codons 844–848
  • genotype-phenotype correlation
  • missense mutation
  • neurofibromatosis type 1
  • plexiform neurofibroma
  • spinal NF

Fingerprint

Dive into the research topics of 'Genotype-Phenotype Correlation in NF1: Evidence for a More Severe Phenotype Associated with Missense Mutations Affecting NF1 Codons 844–848'. Together they form a unique fingerprint.

Cite this